SUBJECTS : Oncology | Cancer | Therapeutic Agent
OncoTargets and Therapy: 2023, vol: 16, issue:
- 1)- . LncRNA FTX Promotes Proliferation and Invasion of Gastric Cancer via miR-144/ZFX Axis [Retraction]. OncoTargets and therapy. 2023, 16: 1013-1014
Cited : 1Read More - 2)- Yan Huang, Shuang Dai, Wenlian Yin, Feng Luo, Yan Li. Sustained Clinical Response to 4th-Line Therapy with Selpercatinib in RET Fusion-Positive Combined Small Cell Lung Cancer. OncoTargets and therapy. 2023, 16: 1015-1020Cited : 1Read More
- 3)- . Hsa_circ_0008945 Promoted Breast Cancer Progression by Targeting miR-338-3p [Retraction]. OncoTargets and therapy. 2023, 16: 1021-1022Cited : 0Read More
- 4)- . MicroRNA-503 Inhibits Non-Small Cell Lung Cancer Progression by Targeting PDK1/PI3K/AKT Pathway [Retraction]. OncoTargets and therapy. 2023, 16: 1023-1024Cited : 0Read More
- 5)- . miR-188-5p Promotes Tumor Growth by Targeting CD2AP Through PI3K/AKT/mTOR Signaling in Children with Acute Promyelocytic Leukemia [Retraction]. OncoTargets and therapy. 2023, 16: 1025-1026Cited : 0Read More
- 6)- Yuteng Ma, Zhe Wang, Jian Sun, Jingtong Tang, Jianping Zhou, Ming Dong. Investigating the Diagnostic and Therapeutic Potential of SREBF2-Related Lipid Metabolism Genes in Colon Cancer. OncoTargets and therapy. 2023, 16: 1027-1042Cited : 0Read More
- 7)- Wenfeng Xu, Hao Tang, Ying Chen, Jiashuang Wang, Zhongjiao Chen, Yujuan Xu, Deyu Guo. Epithelioid Subtype Gastrointestinal Stromal Tumors of Stomach in an Endoscopic Biopsy: A Potential Diagnostic Pitfall. OncoTargets and therapy. 2023, 16: 1043-1049Cited : 0Read More
- 8)- . MLPH Accelerates the Epithelial-Mesenchymal Transition in Prostate Cancer [Retraction]. OncoTargets and therapy. 2023, 16: 1051-1052Cited : 0Read More
- 9)- . ST6GAL2 Downregulation Inhibits Cell Adhesion and Invasion and is Associated with Improved Patient Survival in Breast Cancer [Retraction]. OncoTargets and therapy. 2023, 16: 1053-1054Cited : 0Read More
- 10)- Xiaoli Zhao, Mengze Hao, Xiaoyu Zhang, Jialin Wei, Sizhou Feng, Yi He, Erlie Jiang, Mingzhe Han. Post-HSCT Maintenance Treatment Using Entrectinib for an AML Patient Accompanied with ETV6::NTRK3: A Case Report. OncoTargets and therapy. 2023, 16: 1055-1059Cited : 0Read More
- 11)- Anqing Zhang, Liqin Zhang, Xia Xie, Dan Liu. Inhibition of ATM with KU-55933 Sensitizes Endometrial Cancer Cell Lines to Olaparib. OncoTargets and therapy. 2023, 16: 1061-1071Cited : 1Read More
- 12)- . Circular RNA Gprc5a Promotes HCC Progression by Activating YAP1/TEAD1 Signalling Pathway by Sponging miR-1283 [Retraction]. OncoTargets and therapy. 2023, 16: 691-692Cited : 0Read More
- 13)- . Circular RNA Induced Cell Apoptosis in Urothelial Carcinoma via Interaction with [Retraction]. OncoTargets and therapy. 2023, 16: 693-694Cited : 0Read More
- 14)- Samuel A Kerk, Javier Garcia-Bermudez, Kivanc Birsoy, Mara H Sherman, Yatrik M Shah, Costas A Lyssiotis. Spotlight on GOT2 in Cancer Metabolism. OncoTargets and therapy. 2023, 16: 695-702Cited : 4Read More
- 15)- Zhaopeng Li, Deyong Bu, Xiaobin Wang, Lin Zhu, Daoyan Lei, Fengling Tang, Xianghua Sun, Cheng Chen, Xiang Ji, Song Bai. Chidamide and Oxaliplatin Synergistically Inhibit Colorectal Cancer Growth by Regulating the RPS27A-MDM2-P53 Axis. OncoTargets and therapy. 2023, 16: 703-721Cited : 2Read More
- 16)- . microRNA-130a is an Oncomir Suppressing the Expression of in Gastric Cancer [Retraction]. OncoTargets and therapy. 2023, 16: 723-724Cited : 0Read More
- 17)- . Berberine Reverses Doxorubicin Resistance by Inhibiting Autophagy Through the PTEN/Akt/mTOR Signaling Pathway in Breast Cancer [Retraction]. OncoTargets and therapy. 2023, 16: 725-726Cited : 0Read More
- 18)- . Long Noncoding RNA UCA1 Promotes the Proliferation, Invasion, and Migration of Nasopharyngeal Carcinoma Cells via Modulation of miR-145 [Retraction]. OncoTargets and therapy. 2023, 16: 727-728Cited : 0Read More
- 19)- . MYO5A Inhibition by miR-145 Acts as a Predictive Marker of Occult Neck Lymph Node Metastasis in Human Laryngeal Squamous Cell Carcinoma [Retraction]. OncoTargets and therapy. 2023, 16: 729-730Cited : 0Read More
- 20)- Dehua Liao, Jiwen Zhang, Ting Yan, Shanshan Chen, Wei Li, Dangang Shangguan, Zhihua She. Recent Advances in the Management of Adverse Events Associated with Lorlatinib. OncoTargets and therapy. 2023, 16: 731-738Cited : 1Read More
- 21)- Nan Meng, Ping Han, Liwei Liu, Jiqiao Liu, Jingmei Liu. Colon Metastasis from Pancreatic Cancer: A Case Report. OncoTargets and therapy. 2023, 16: 739-744Cited : 0Read More
- 22)- . Long Noncoding RNA PVT1 Promotes Prostate Cancer Metastasis by Increasing NOP2 Expression via Targeting Tumor Suppressor MicroRNAs [Retraction]. OncoTargets and therapy. 2023, 16: 745-746Cited : 0Read More
- 23)- . Lamin B1 Overexpresses in Lung Adenocarcinoma and Promotes Proliferation in Lung Cancer Cells via AKT Pathway [Retraction]. OncoTargets and therapy. 2023, 16: 747-748Cited : 0Read More
- 24)- . MiR-29a Function as Tumor Suppressor in Cervical Cancer by Targeting SIRT1 and Predict Patient Prognosis [Retraction]. OncoTargets and therapy. 2023, 16: 749-750Cited : 0Read More
- 25)- . MicroRNA-145-5p Inhibits Gastric Cancer Invasiveness through Targeting N-Cadherin and ZEB2 to Suppress Epithelial-Mesenchymal Transition [Retraction]. OncoTargets and therapy. 2023, 16: 751-752Cited : 1Read More
- 26)- Yuan Wu, Xiaoli Liu, Xinhui Wang, Lihua Yu, Huiwen Yan, Yuqing Xie, Qing Pu, Xue Cai, Yaxian Kong, Zhiyun Yang. A Nomogram Prognostic Model for Advanced Hepatocellular Carcinoma Based on the Interaction Between CD8T Cell Counts and Age. OncoTargets and therapy. 2023, 16: 753-766Cited : 0Read More
- 27)- Xue Gu, Xiaoli Li, Xue Zhang, Li Tong, Ran Feng, Lei Liu, Hui Sun, Qing Zhang, Tingting Bian, Jianguo Zhang, Lihua Gao, Chenxi Zhang, Jian Liu, Yifei Liu. Noncoding RNA-Mediated High Expression of PFKFB3 Correlates with Poor Prognosis and Tumor Immune Infiltration of Lung Adenocarcinoma. OncoTargets and therapy. 2023, 16: 767-783Cited : 0Read More
- 28)- Mona S Abdellateif, Ahmed K Bayoumi, Mohammed Aly Mohammed. c-Kit Receptors as a Therapeutic Target in Cancer: Current Insights. OncoTargets and therapy. 2023, 16: 785-799Cited : 6Read More
- 29)- . Loss of miR-204-5p Promotes Tumor Proliferation, Migration, and Invasion Through Targeting YWHAZ/PI3K/AKT Pathway in Esophageal Squamous Cell Carcinoma [Retraction]. OncoTargets and therapy. 2023, 16: 801-802Cited : 0Read More
- 30)- Michele Massimino, Stefania Stella, Elena Tirrò, Maria Stella Pennisi, Fabio Stagno, Silvia Rita Vitale, Chiara Romano, Cristina Tomarchio, Nunziatina Laura Parrinello, Livia Manzella, Francesco Di Raimondo, Paolo Vigneri. High Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability. OncoTargets and therapy. 2023, 16: 803-816Cited : 0Read More
- 31)- . Inhibits Cell Proliferation and Migration and Promotes Apoptosis via the CTHRC1/AKT/ERK Pathway in Esophageal Squamous Cell Carcinoma [Retraction]. OncoTargets and therapy. 2023, 16: 817-818Cited : 0Read More
- 32)- Zhixing Xu, Haitao Xu, Xi Chen, Xiaobing Huang, Jintao Tian, Jinxi Zhao, Bohu Liu, Fengcai Shi, Jin Wu, Jun Pu. CCDC103 as a Prognostic Biomarker Correlated with Tumor Progression and Immune Infiltration in Glioma. OncoTargets and therapy. 2023, 16: 819-837Cited : 0Read More
- 33)- . Identification of Osteosarcoma Metastasis-Associated Gene Biomarkers and Potentially Targeted Drugs Based on Bioinformatic and Experimental Analysis [Retraction]. OncoTargets and therapy. 2023, 16: 839-840Cited : 0Read More
- 34)- . MicroRNA-188-5p Promotes Epithelial-Mesenchymal Transition by Targeting ID4 Through Wnt/β-Catenin Signaling in Retinoblastoma [Retraction]. OncoTargets and therapy. 2023, 16: 841-842Cited : 0Read More
- 35)- . Long Non-Coding RNA LEF1-AS1 Promotes Migration, Invasion and Metastasis of Colon Cancer Cells Through miR-30-5p/SOX9 Axis [Retraction]. OncoTargets and therapy. 2023, 16: 843-844Cited : 0Read More
- 36)- . LncRNA EWSAT1 Promotes Colorectal Cancer Progression Through Sponging miR-326 to Modulate FBXL20 Expression [Retraction]. OncoTargets and therapy. 2023, 16: 845-846Cited : 0Read More
- 37)- . LncRNA SNHG7 Functions as an Oncogene in Cervical Cancer by Sponging miR-485-5p to Modulate JUND Expression [Retraction]. OncoTargets and therapy. 2023, 16: 847-848Cited : 0Read More
- 38)- Yunhe Xie, Jiarong Ye, Hongliang Luo. HOXC Cluster Antisense RNA 3, a Novel Long Non-Coding RNA as an Oncological Biomarker and Therapeutic Target in Human Malignancies. OncoTargets and therapy. 2023, 16: 849-865Cited : 1Read More
- 39)- Xinyi Zhang, Fengxi Li, Rong Li, Nan Zhao, Dianfeng Liu, Yuelin Xu, Lei Wang, Dongxu Wang, Ruihong Zhao. B7 Induces Apoptosis in Colorectal Cancer Cells by Regulating the Expression of Caspase-3 and Inhibits Autophagy. OncoTargets and therapy. 2023, 16: 867-883Cited : 1Read More
- 40)- Ling Chen, Zhe Meng, Zhiguo Zhou, Xiaomin Li, Liyan Zhao, Zhaohui Jia, Jingli Chen, Ye Tian, Qingju Meng, Yibing Liu. Immunotherapy Combined with Chemotherapy in Relapse Metaplastic Breast Cancer. OncoTargets and therapy. 2023, 16: 885-890Cited : 1Read More
- 41)- Victoriano Mendieta-Carmona, Guadalupe Delgado-López, Julio Reyes-Leyva, Claudia Teresita Gutiérrez-Quiroz, Víctor Javier Vazquez-Zamora, Denisse Alejandra Picazo-Mendoza, Alvaro José Montiel-Jarquín, Laura Patricia Martinez-Morales, Verónica Vallejo-Ruiz. Galectin-9 Expression is Correlated to Cervical Squamous Cell Carcinoma Progression and Overall Survival. OncoTargets and therapy. 2023, 16: 891-904Cited : 0Read More
- 42)- Zhou Zhu, Na Zhou, Shuangni Yu, Xin Gao, Xin Cheng, Yingyi Wang, Chunmei Bai. Successful Treatment of Concurrent Follicular Lymphoma and Triple-Negative Breast Cancer Using Rituximab Plus Nab-Paclitaxel and Cisplatin: A Case Report and Literature Review. OncoTargets and therapy. 2023, 16: 905-911Cited : 1Read More
- 43)- Xuan Wan, Yuting Fang, Jiangzhou Du, Shaoxi Cai, Hangming Dong. GW4869 Can Inhibit Epithelial-Mesenchymal Transition and Extracellular HSP90α in Gefitinib-Sensitive NSCLC Cells. OncoTargets and therapy. 2023, 16: 913-922Cited : 3Read More
- 44)- Zhitao Chen, Yahui He, Chenchen Ding, Jun Chen, Yangjun Gu, Min Xiao, Qiyong Li. Safety and Efficacy Analysis of PD-1 Inhibitors in Combination with Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer: A Real-World, Single-Center Study. OncoTargets and therapy. 2023, 16: 923-935Cited : 0Read More
- 45)- . miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer [Retraction]. OncoTargets and therapy. 2023, 16: 937-938Cited : 0Read More
- 46)- Yunxiang Zhou, Xianan Guo, Lu Shen, Kexin Liu, Qunan Sun, Yali Wang, Hui Wang, Wenyu Fu, Yihan Yao, Shijie Wu, Huihui Chen, Jili Qiu, Tao Pan, Yongchuan Deng. Predictive Significance of Systemic Immune-Inflammation Index in Patients with Breast Cancer: A Retrospective Cohort Study. OncoTargets and therapy. 2023, 16: 939-960Cited : 0Read More
- 47)- Fan-Jie Qu, Yi Zhou, Hai Wang. Oral Anlotinib Maintenance Therapy for an Advanced Malignant Peritoneal Mesothelioma Diagnosed by Laparoscopy After Initial Misdiagnosis to Obtain Longer Progression-Free Survival: Case Report and Literature Review. OncoTargets and therapy. 2023, 16: 961-972Cited : 0Read More
- 48)- William G North. Cancer and the Vasopressin Gene: Radioimmunoassay Values and Commentary on Copeptin as a Plasma Marker. OncoTargets and therapy. 2023, 16: 973-982Cited : 0Read More
- 49)- Zi-Qi Li, Guo-Song Zhang, Ri-Qun Liu, Shu-Yuan Shuai, Peng-Yi Hu, Qin Zheng, Shu-Hua Xiao. Anti-Glioma Effects of Ligustilide or n-Butylphthalide on Their Own and the Synergistic Effects with Temozolomide via PI3K/Akt Signaling Pathway. OncoTargets and therapy. 2023, 16: 983-994Cited : 0Read More
- 50)- Beatrice Riccò, Giulio Martinelli, Camilla Bardasi, Massimo Dominici, Andrea Spallanzani, Massimiliano Salati. Optimizing the Continuum of Care in Gastric Cancer. OncoTargets and therapy. 2023, 16: 995-1012Cited : 0Read More
